Nice numbers [Regulatives / Guidelines]

posted by Beholder  – Russia, 2018-06-22 08:33 (950 d 05:31 ago) – Posting: # 18946
Views: 5,973

Hi, Helmut!

» We find nice numbers which are “easy to remember” everywhere.

Thx a lot for clarification.

Im just comparing the EU legislation and EEU legislation because it is very similar. May be you or other members of the forum know how can one understand whether we need to perform BEQ study in case of changes in amount of tablets in production batch or not? I refer to the table B.II.b.4 Change in the batch size (including batch size ranges) of the finished product which says (point c):
c) The change requires assessment of the comparability of a biological/immunological medicinal product or the change in batch size requires a new bioequivalence study
(my emphasis)

Best regards
Beholder

Complete thread:

Activity
 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 6 (0 registered, 6 guests [including 3 identified bots]).
Forum time: Wednesday 14:05 UTC (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5